Clinical study of electroacupuncture improving sleep electroencephalogram and event-related potential in patients with somatoform disorders
Zhanwen Liu,Li Zhang,Minmin Zhang,Xueqian Hu,Xingshi Chen,Jie Su
DOI: https://doi.org/10.1007/s11726-024-1422-8
2024-02-20
Journal of Acupuncture and Tuina Science
Abstract:Objective To observe the effects of electroacupuncture (EA) on sleep electroencephalogram (EEG) and event-related potential (ERP) in patients with somatoform disorders (SFD). Methods Seventy-five SFD patients were recruited as an EA group to receive EA at Shenting (GV24) and Baihui (GV20) once daily, 30 min each time, with 6 straight days as a treatment course, and 4 courses were conducted at 1-day intervals. Before treatment, patients underwent a survey using a physical symptom checklist on their primary symptoms. Before and after treatment, their sleep EEG was monitored using Quisi, and the ERP mismatch negativity (MMN) and P300 were detected. The Quisi sleep EEG and ERP were also examined among 40 normal volunteers as the normal group data. Results During the trial, 13 cases were removed from the EA group due to incomplete data, and 62 cases were finally included for statistical analyses. Of the 62 SFD patients, the main disturbing symptoms were cognitive impairments, sleep disorders, respiratory symptoms, digestive symptoms, five-sense organ problems, and cardiovascular symptoms in order. Before treatment, the EA group had increased MMN and P300 latencies and decreased amplitudes compared with the normal control group ( P <0.01 or P <0.05); according to Quisi, the EA group also had reduced total sleep time (TST), shorter rapid eye movement sleep (REM) latency (RL) and REM time (RT), smaller number of REM period (NRP), extended sleep latency (SL), longer awaking time (AT), lower sleep efficiency (SE), larger percent of non-rapid eye movement sleep (NREM) stage 1 (S 1 ) and smaller percent of NREM stage 2 (S 2 ), and the percent of slow wave sleep (SWS), i.e. NREM stage 3 (S 3 ) plus stage 4 (S 4 ), also went down, all presenting significant differences between groups ( P <0.01 or P <0.05). After 4 courses of treatment, the MMN and P300 latencies were reduced, and their amplitudes became larger in the EA group compared with the baseline ( P <0.05); they had insignificant differences compared with the normal control group ( P >0.05). Quisi showed that the TST and RL increased, and the SL and AT decreased in the EA group, and the predominant change in sleep architecture was reduced S 1 percent, increased S 2 , and improved SE, all showing significant intra-group differences ( P <0.01 or P <0.05); however, the intra-group difference in the NRP was statistically insignificant ( P >0.05). Except the TST, RT, S 1 percent, and SWS, there was no statistical significance in comparing the other Quisi parameters (including RL, NRP, SL, AT, SE, and S 2 percent) between the two groups ( P >0.05). Conclusion SFD patients have a variety of clinical symptoms, and most of them show abnormal sleep EEG and ERP; EA can correct abnormal sleep EEG parameters and the MMN and P300 of ERP in SFD patients.
integrative & complementary medicine